Position in NVS
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$28,563,787
+$708,908 QoQ
Shares Held
182,260
-0.1% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.46%
of 13F equity value
Holder Rank
#93
of 1,603 holders
Holding Since
Mar 2020
6 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FERGUSON WELLMAN CAPITAL MANAGEMENT, INC holds $482,832,960 across 10 Drug Manufacturers - General names. NVS ranks #5 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
656,778 | $165,271,615 | |
| 2 | JNJ |
Johnson & Johnson
|
472,770 | $120,069,396 | |
| 3 | AMGN |
Amgen Inc
|
247,072 | $89,469,711 | |
| 4 | MRK |
Merck & Co., Inc.
|
376,644 | $48,398,753 | |
| 5 | NVS |
Novartis AG
This page
|
182,260 | $28,563,787 | |
| 6 | LLY |
ELI LILLY & Co
|
21,322 | $25,574,248 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
45,554 | $2,624,821 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
14,789 | $1,868,442 |
All Filings in NVS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,563,787 | 182,260 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $27,854,879 | 182,356 | Shares | Sole | 2026-05-01 | |
| 2020-12-31 | $2,203,429 | 23,334 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $2,029,124 | 23,334 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $2,043,231 | 23,394 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $1,928,835 | 23,394 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||